Page last updated: 2024-11-07

dehydroepiandrosterone and Ovarian Hyperstimulation Syndrome

dehydroepiandrosterone has been researched along with Ovarian Hyperstimulation Syndrome in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.

Research Excerpts

ExcerptRelevanceReference
"Preterm ovarian hyperstimulation syndrome is a rare syndrome in which preterm infant girls have hypogastric, upper leg and labial swelling accompanied by elevated serum oestradiol levels and ovarian follicular cysts on ultrasound."1.46Atypical case of preterm ovarian hyperstimulation syndrome. ( Durst, MA; Narvey, M; Wicklow, B, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durst, MA1
Wicklow, B1
Narvey, M1
Gustafson, O1
Carlström, K1
Nylund, L1

Other Studies

2 other studies available for dehydroepiandrosterone and Ovarian Hyperstimulation Syndrome

ArticleYear
Atypical case of preterm ovarian hyperstimulation syndrome.
    BMJ case reports, 2017, Feb-22, Volume: 2017

    Topics: 17-alpha-Hydroxyprogesterone; Clitoris; Dehydroepiandrosterone; Estradiol; Female; Humans; Infant; I

2017
Androstenedione as a predictor of ovarian hyperstimulation syndrome.
    Human reproduction (Oxford, England), 1992, Volume: 7, Issue:7

    Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Homeostasis;

1992